A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

540

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Alzheimer Disease
Interventions
DRUG

sabirnetug

Intravenous sabirnetug

DRUG

Placebo

Intravenous Placebo

Trial Locations (69)

12208

Neurological Associates of Albany, Albany

19001

Abington Neurological Associates, Abington

19462

Keystone Clinical Research, Norristown

22031

Re:Cognition Health - Fairfax, Washington D.C.

28105

AMC Research, Matthews

30030

CenExel - iResearch Atlanta, Decatur

31909

Columbus Memory Center, Columbus

32127

Progressive Medical Research, Port Orange

32159

K2 Medical Research - Villages, Lady Lake

32162

Charter Research - Lady Lake, The Villages

32789

Conquest Research, Winter Park

32792

Charter Research - Winter Park, Winter Park

33032

Coral Clinical Research, Homestead

33126

Finlay Medical Research, Miami

33135

Gil Fernandez-Yera, MD, PA, Coral Gables

33414

Alzheimers Research and Treatment Center - Wellington, Wellington

33445

Brain Matters Research, Delray Beach

33462

JEM Research Institute, Atlantis

33607

K2 Medical Research - Tampa, Tampa

34205

Bradenton Research Center, Bradenton

34470

Ocala Health - Family Care Specialists - Ocala I, Ocala

34997

Alzheimer's Research and Treatment Center - Stuart, Stuart

38018

Neurology Clinic. P.C, Cordova

44195

Cleveland Clinic, Cleveland

60640

Office of Jeffrey S. Ross, MD, Northbrook

75231

Kerwin Medical Center, Dallas

77702

Gadolin Research, LLC, Beaumont

78757

Senior Adult Specialty Research, Austin

90804

Healthy Brain Research, Long Beach

92614

Irvine Medical Research, Irvine

92705

Syrentis Clinical Research, Santa Ana

92835

Neurology Center of North Orange County, Fullerton

97210

Summit Research Network, Portland

92011-4219

The Neurology Center of Southern California - Carlsbad, Carlsbad

91403-2131

CenExel - California Neuroscience Research Medical Group, Inc (CNR), Sherman Oaks

06851-4903

Research Center for Clinical Studies, LLC, Norwalk

34105-8522

Collier Neurologic Specialists (CNS), L.L.C., Naples

02459

Boston Center for Memory, Newton

39401-7246

Hattiesburg Clinic - Memory Center, Hattiesburg

03801

ActivMed Practices and Research, Portsmouth

07081

The Cognitive and Research Center of New Jersey, Springfield

08755

CenExel - Advanced Memory Research Institute of NJ, Toms River

02914

Rhode Island Mood and Memory, East Providence

37920-1511

The Alliance for Multispecialty Research LLC (AMR), Knoxville

Unknown

Okanagan Clinical Trials, Kelowna

Hippocampe d/b/a Ottawa Memory Clinic, Ottawa

Toronto Memory Program (TMP) (Neurology Research Inc.), Toronto

MoCA Research and Innovations, Greenfield Park

Charité - Universitaetsmedizin Berlin, Berlin

University Hospital of Cologne, Cologne

Zentralinstitut für seelische Gesundheit, Mannheim

Technical University of Munich, School of Medicine and Health, Klinikum rechts der Isar, Munich

Hospital Universitari General de catalunya, Sant Cugat del Vallès

Fundacion Neuropolis - Hospital Viamed Montecanal, Cuarte de Huerva

Fundacio ACE, Barcelona

Policlínica Gipuzkoa, Donostia / San Sebastian

Cae Oroitu, Getxo

Hospital Ruber, Madrid

Hospital Victoria Eugenia, Seville

Hospital Universitari i Politècnic La Fe, Valencia

Re:Cognition Health - London, London

St. Pancras Clinical Research Ltd., London

Panthera Bio-Partners - Rochdale, Rochdale

Re:Cognition Health - Winchester, Winchester

Neuroclin Glasgow, Motherwell

Panthera Bio-Partners - Preston, Preston

Re:Cognition Health - Guildford, Guildford

Panthera Biopartners - Sheffield, Sheffield

Re:Cognition Health - Bristol, Bristol

Sponsors
All Listed Sponsors
lead

Acumen Pharmaceuticals

INDUSTRY